FDA moves to make generic drugmakers more accountable

08-11-2013 Today.comComments (0)


In a 5-4 decision, the justices found generic drugmakers can't be sued because, under current FDA rules, only name-brand drugmakers are responsible for safety warnings. Generics are required to copy the label from the name brand and have no control ...

Read more on Today.com

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top